More Pricing Charges Against Drug Firms

As I noted earlier, you really need to have your pricing process in order to stay in compliance with the law, especially in healthcare, where the government is spending our tax dollars on medicine. A lot of the violations of these laws are the result of inefficient, manual, error-prone processes, not necessarily deliberate fraud. Regardless, companies are liable (and I don’t want them wasting my tax dollars, either). Now, state and federal officals are investigating 150 cases of overpricing by drugs firms, which could lead to $1B or more in fines. Maybe these companies, already awash in cash, should have invested a few million to make sure their pricing systems worked properly.

Comments are closed.